The use of budesonide in the treatment of active Crohn's disease is good clinical practice.
Rutgeerts
P
P
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001682:Biological Availability; D019819:Budesonide / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D019819:Budesonide